Skip to main content
Caplight Logo









InsightRX

InsightRX

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.insight-rx.com/

Last Round

Debt

Feb 24, 2024

Total Funding Raised

$12.83M

Company Overview

InsightRX is a healthcare technology company that provides a cloud-based platform for precision medicine and clinical analytics designed to individualize drug treatment from clinical development to the point of care.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, Medical AI, Clinical Trials, EHR & EMR

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

precision drug dosingclinical decision supportmodel-informed precision dosingpharmacometricsEHR integrationtherapeutic drug monitoringPK/PD modelingBayesian modelingHealthTechmedical AIdosing calculatorclinical analyticsadverse drug event reductioncompanion applicationsclinical trial softwareclinical pharmacology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InsightRX Comparables

Compare InsightRX with similar companies based on industry and business-model similarity.

InsightRX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fairlong Capital LLC
91%
PrecisePK
89%
MEDIWARE a.s.
80%

InsightRX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtFeb 24, 2024
Series ASep 20, 2019
SeedMay 22, 2017

Key People

Founding team and executive leadership

Sirj Goswami

Founder CEO

Founding Team

InsightRX Investors

Notable investors and investment history

InsightRX investors
InvestorRounds
GreatPoint VenturesSeries A, Seed
Rock HealthSeries A
HealthX VenturesSeries A
OSF VenturesSeed
CIBC Innovation BankingDebt
Leawood Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 33% MoM, from 4K to 5.3K.

  • Feb 3, 2026

    Monthly visitors grew 69% MoM, reaching 9.8K.

InsightRX Filings

Explore SEC and related filing metadata, where available.

InsightRX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InsightRX's valuation, stock price, and market status.

Is InsightRX a public or private company?

InsightRX is a private company.

What is the current stock price of InsightRX?

InsightRX is a private company with no public stock price. No recent secondary market data is available.

How much is InsightRX worth (valuation)?

Valuation information for InsightRX is not publicly available.

Can I buy InsightRX stock?

InsightRX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was InsightRX's last funding round?

InsightRX's most recent funding round was Debt on February 24, 2024.

Who are the main investors in InsightRX?

Key investors in InsightRX include GreatPoint Ventures, HealthX Ventures.

Will InsightRX IPO soon?

No public IPO plans have been announced for InsightRX.

How can I track InsightRX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InsightRX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range24
Year Founded2015
Last FundingFeb 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?